Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022

SELL
$36.54 - $48.66 $558,331 - $743,524
-15,280 Reduced 44.11%
19,360 $856,000
Q2 2022

Aug 03, 2022

BUY
$31.71 - $43.0 $1.1 Million - $1.49 Million
34,640 New
34,640 $1.28 Million
Q4 2020

Feb 05, 2021

SELL
$45.3 - $60.27 $252,683 - $336,186
-5,578 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$47.45 - $62.95 $3,368 - $4,469
71 Added 1.29%
5,578 $265,000
Q2 2020

Aug 12, 2020

BUY
$46.85 - $61.05 $258,002 - $336,202
5,507 New
5,507 $325,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Knowledge Leaders Capital, LLC Portfolio

Follow Knowledge Leaders Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knowledge Leaders Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knowledge Leaders Capital, LLC with notifications on news.